United Laboratories International Unit's Antibiotic Drug Passes Chinese Regulator's Consistency Evaluation

MT Newswires Live

2024/10/28

United Laboratories International (HKG:3933) said Oct. 25 that ceftazidime for injection submitted by unit Zhuhai United Laboratories, Zhongshan Branch, has passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic drugs, a same-day bourse filing said.

The drug is a third-generation cephalosporin antibiotic and is used to treat infections caused by susceptible microorganisms, including severe systemic, lower respiratory tract, and urinary tract infections among others.

Price (HKD): $11.10, Change: $-0.100, Percent Change: -0.89%

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2478610486"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478610486\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2478610486?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 19:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478610486","market":"sg","top_or_hot":-1,"title":"United Laboratories International Unit's Antibiotic Drug Passes Chinese Regulator's Consistency Evaluation","media":"MT Newswires Live","content":"<html><body><p> United Laboratories International (HKG:3933) said Oct. 25 that ceftazidime for injection submitted by unit Zhuhai United Laboratories, Zhongshan Branch, has passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic drugs, a same-day bourse filing said.</p><p>The drug is a third-generation cephalosporin antibiotic and is used to treat infections caused by susceptible microorganisms, including severe systemic, lower respiratory tract, and urinary tract infections among others.</p><p>Price (HKD): $11.10, Change: $-0.100, Percent Change: -0.89%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>United Laboratories International Unit's Antibiotic Drug Passes Chinese Regulator's Consistency Evaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnited Laboratories International Unit's Antibiotic Drug Passes Chinese Regulator's Consistency Evaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-28 19:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> United Laboratories International (HKG:3933) said Oct. 25 that ceftazidime for injection submitted by unit Zhuhai United Laboratories, Zhongshan Branch, has passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic drugs, a same-day bourse filing said.</p><p>The drug is a third-generation cephalosporin antibiotic and is used to treat infections caused by susceptible microorganisms, including severe systemic, lower respiratory tract, and urinary tract infections among others.</p><p>Price (HKD): $11.10, Change: $-0.100, Percent Change: -0.89%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UBCP","symbol_name":"联合合众银行","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478610486","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478610486","pubTimestamp":1730116757,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"United Laboratories International  said Oct. 25 that ceftazidime for injection submitted by unit Zhuhai United Laboratories, Zhongshan Branch, has passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic drugs, a same-day bourse filing said.The drug is a third-generation cephalosporin antibiotic and is used to treat infections caused by susceptible microorganisms, including severe systemic, lower respiratory tract, and urinary tract infections among others.Price : $11.10, Change: $-0.100, Percent Change: -0.89%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UBCP":"联合合众银行","HKD":"尚乘数科","03933":"联邦制药","BK4526":"热门中概股","BK1191":"制药","BK4211":"区域性银行","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4023":"应用软件"},"translate_title":"联邦制药国际子公司抗生素药物通过中国监管机构一致性评价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"UBCP":1,"03933":0.9},"content_text":"United Laboratories International (HKG:3933) said Oct. 25 that ceftazidime for injection submitted by unit Zhuhai United Laboratories, Zhongshan Branch, has passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic drugs, a same-day bourse filing said.The drug is a third-generation cephalosporin antibiotic and is used to treat infections caused by susceptible microorganisms, including severe systemic, lower respiratory tract, and urinary tract infections among others.Price (HKD): $11.10, Change: $-0.100, Percent Change: -0.89%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}